Stem Cells/Stem Cell Transplantation Clinical Trials

• Mobilization of Stem Cells with AMD3100 in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00103662 - Active, not recruiting
  Multiple Myeloma
  
• Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005998 - Active, not recruiting
  Hodgkin's Disease; Lymphocytic Lymphoma
  
• Mobilization of Stem Cells with AMD3100 in Non-Hodgkin's Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00103610 - Active, not recruiting
  Lymphoma, Non-Hodgkin
  
• Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00143559 - Active, not recruiting
  Neoplasm, leukemia, myeloid; Lymphoma, Non-Hodgkin; Stem Cell Transplantation; Myelodysplastic Syndromes; Hepatic Cancer
  
• Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
  
• Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child
  ClinicalTrials.gov Identifier: NCT00180986 - Active, not recruiting
  Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)
  
• Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00005896 - Active, not recruiting
  Fanconi's Anemia
  
• Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00179075 - Recruiting
  Hematopoietic Stem Cell Transplantation; Graft vs Host Disease
  
• Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00179049 - Recruiting
  Hematopoietic Stem Cell Transplantation; Graft vs Host Disease
  
• Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
  ClinicalTrials.gov Identifier: NCT00005930 - Recruiting
  Hematopoietic Stem Cell Mobilization
  
• Nutrition Support in Pediatric Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00115258 - Recruiting
  Hematopoietic Stem Cell Transplantation
  
• Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus after Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00078533 - Recruiting
  Stem Cell Transplantation; Cytomegalovirus Infections
  
• Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
  ClinicalTrials.gov Identifier: NCT00003163 - Active, not recruiting
  Lymphoma; Multiple Myeloma
  
• High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060255 - Active, not recruiting
  Cancer
  
• A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation.
  ClinicalTrials.gov Identifier: NCT00429039 - Recruiting
  ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
  
• Safety, Efficacy and Pharmacokinetics Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00148148 - Recruiting
  "Hematopoietic Stem Cell Transplantation"
  
• Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
  ClinicalTrials.gov Identifier: NCT00075621 - Active, not recruiting
  primary systemic amyloidosis
  
• Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
  ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Haploidentical Stem Cell (HSC)Transplantation for Sickle Cell Disease Patients with a Stroke/Abnormal TCD
  ClinicalTrials.gov Identifier: NCT00152113 - Active, not recruiting
  Sickle Cell Disease
  
• Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation in Treating Patients With Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00083135 - Active, not recruiting
  recurrent neuroblastoma
  
• Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor
  ClinicalTrials.gov Identifier: NCT00531583 - Recruiting
  Leukemia, Monocytic, Acute
  
• Investigating Cytokine Genes of Stem Cell Donors
  ClinicalTrials.gov Identifier: NCT00353821 - Active, not recruiting
  Stem Cell Transplantation
  
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003173 - Active, not recruiting
  Testicular Cancer; Brain Tumor; Eye Cancer
  
• Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
  ClinicalTrials.gov Identifier: NCT00275678 - Recruiting
  Blood Stem Cell Transplant
  
• Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00052923 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
  ClinicalTrials.gov Identifier: NCT00008307 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005090 - Active, not recruiting
  adult Hodgkin's disease
  
• Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00073879 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Induction of Stable Chimerism for Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00029393 - Active, not recruiting
  Blood Disease; Hematopoietic Stem Cell Transplantation; Anemia, Sickle Cell
  
• Vaccination of Children Following Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00169728 - Active, not recruiting
  Allogeneic Haematopoietic Stem Cell Transplantation
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002926 - Active, not recruiting
  Myelodysplastic Syndromes; Myeloid Leukemia; Refractory Anemia; Refractory Cytopenia
  
• Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00024193 - Active, not recruiting
  stage 4S neuroblastoma
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00027924 - Active, not recruiting
  Myeloid Leukemia; Refractory Anemia
  
• Cord Blood Stem Cell Transplantation Study (COBLT)
  ClinicalTrials.gov Identifier: NCT00000603 - Active, not recruiting
  Anemia, Aplastic; Fanconi Anemia; Hematologic Diseases; Leukemia; Neoplasms; Severe Combined Immunodeficiency; ...
  
• Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002836 - Active, not recruiting
  recurrent breast cancer
  
• Effects of Stem Cell Transplantation on Bacteria in the Mouth
  ClinicalTrials.gov Identifier: NCT00476450 - Recruiting
  Allogeneic Peripheral Blood Stem Cell Transplant
  
• Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients
  ClinicalTrials.gov Identifier: NCT00402753 - Recruiting
  Hematopoietic Stem Cell Transplantation
  
• Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00002792 - Active, not recruiting
  Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia
  
• Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002521 - Active, not recruiting
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ...
  
• Second Autologous Stem Cell Transplantation in Treating Patients With Persistent or Recurrent Primary Systemic (AL) Amyloidosis
  ClinicalTrials.gov Identifier: NCT00075608 - Recruiting
  primary systemic amyloidosis
  
• Glucose Control In Hematopoetic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00582036 - Recruiting
  Hyperglycemia; Hematopoietic Stem Cell Transplantation
  
• Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00073931 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis
  ClinicalTrials.gov Identifier: NCT00017680 - Active, not recruiting
  Amyloidosis
  
• Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00044954 - Active, not recruiting
  Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Peripheral Stem Cell Transplantation Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
  ClinicalTrials.gov Identifier: NCT00004143 - Active, not recruiting
  Breast Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; skin tumor
  
• Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
  
• Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplantation Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00011921 - Active, not recruiting
  limited stage small cell lung cancer; extensive stage small cell lung cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003852 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; pediatric germ cell tumor; extragonadal germ cell tumor
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00025636 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma
  
• Donor Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00054327 - Recruiting
  childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00004231 - Active, not recruiting
  stage III mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
  ClinicalTrials.gov Identifier: NCT00003273 - Active, not recruiting
  childhood brain tumor; childhood rhabdomyosarcoma; Neuroblastoma; Retinoblastoma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003194 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002638 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia
  
• Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00068523 - Active, not recruiting
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
  ClinicalTrials.gov Identifier: NCT00025558 - Active, not recruiting
  adult brain tumor; childhood central nervous system germ cell tumor; childhood ependymoma; Childhood Medulloblastoma; ...
  
• Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002566 - Active, not recruiting
  recurrent testicular cancer; extragonadal germ cell tumor
  
• Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
  ClinicalTrials.gov Identifier: NCT00582894 - Recruiting
  Hematological Neoplasms; Hematopoietic Stem Cell Transplantation
  
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006123 - Active, not recruiting
  stage IV breast cancer
  
• Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005787 - Active, not recruiting
  Lymphocytic Lymphoma; Myeloid Lymphoma; Neutropenia
  
• Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003541 - Active, not recruiting
  stage IV mantle cell lymphoma; stage III mantle cell lymphoma
  
• Fludarabine and Melphalan Followed by Tacrolimus and Methotrexate in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00121186 - Active, not recruiting
  adult Hodgkin''s lymphoma; adult non-Hodgkin''s lymphoma
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002854 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer
  
• T-Cell-Depleted Allogeneic Stem Cell Transplantation Followed By Donor T Cells, Given After Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082953 - Recruiting
  Breast Cancer
  
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002649 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Cyclophosphamide With or Without Rituximab and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00028665 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Allogeneic Stem Cell Transplantation in Treating Patients With Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00056095 - Recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00025324 - Active, not recruiting
  childhood central nervous system germ cell tumor; adult central nervous system germ cell tumor
  
• Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00112645 - Recruiting
  unspecified childhood solid tumor, protocol specific
  
• Mycophenolate Mofetil for the Prophylaxis of Graft-Versus-Host Disease in High Risk Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00563589 - Recruiting
  Graft vs Host Disease; Hematopoietic Stem Cell Transplantation
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003215 - Active, not recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
  
• High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00002948 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00025519 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma
  
• Combination Chemotherapy Plus Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00027560 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00052884 - Active, not recruiting
  Drug Toxicity; primary systemic amyloidosis
  
• Donor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00047268 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; juvenile myelomonocytic leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002548 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Study of Peripheral Stem Cell Transplantation After Chemotherapy and Radiation Therapy in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005851 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00005978 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; ...
  
• GnRH Analogue for Ovarian Function Preservation In Hematopoietic Stem Cell Transplant Patients
  ClinicalTrials.gov Identifier: NCT00429494 - Recruiting
  Hematopoietic Stem Cell Transplantation
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00006367 - Active, not recruiting
  idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Agnogenic Myeloid Metaplasia
  
• Peripheral Stem Cell Transplantation, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
  ClinicalTrials.gov Identifier: NCT00005941 - Active, not recruiting
  Cervical Cancer; Vaginal Cancer
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002941 - Active, not recruiting
  recurrent childhood lymphoblastic lymphoma; childhood diffuse large cell lymphoma; childhood immunoblastic large cell lymphoma; ...
  
• A Prospective Pilot Study in Order to Evaluate the Place of Thymoglobuline in Non-Myeloablative Allogeneic Stem-Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00130754 - Completed
  Stem Cell Transplantation; Graft vs Host Disease
  
• Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003042 - Active, not recruiting
  stage IIIB breast cancer; inflammatory breast cancer
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Previously Untreated Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003941 - Active, not recruiting
  bone metastases; brain metastases; liver metastases; Mediastinal Cancer; Testicular Cancer
  
• Basiliximab for the Treatment of Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00563108 - Recruiting
  Graft vs Host Disease; Hematopoietic Stem Cell Transplantation
  
• Sibling Donor Cord Blood Banking and Transplantation
  ClinicalTrials.gov Identifier: NCT00029380 - Recruiting
  Blood Disease; Anemia, Sickle Cell; Anemia (Cooley's); Leukemia; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation
  
• Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00020943 - Active, not recruiting
  stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00004135 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005993 - Active, not recruiting
  Lymphoma; Breast Cancer
  
• Multimodal Intervention in Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00427115 - Recruiting
  Patients Undergoing Allogeneic Stem Cell Transplantations
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplantation Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00016887 - Active, not recruiting
  stage III mantle cell lymphoma; stage IV mantle cell lymphoma
  
• Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
  ClinicalTrials.gov Identifier: NCT00025103 - Recruiting
  recurrent Wilms' tumor and other childhood kidney tumors; clear cell sarcoma of the kidney
  
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00008216 - Recruiting
  Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002658 - Active, not recruiting
  Myeloid Leukemia; Neutropenia
  
• Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025649 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00078949 - Recruiting
  anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer